Abbott to Acquire Exact Sciences in $21 Billion Agreement
The deal positions Abbott to enter the US cancer screening and precision oncology diagnostics market with products including Cologuard and Oncotype DX tests.
Latest Articles
Editor's Top Picks
FDA Clears Automated Platform for Multiple Myeloma Diagnosis
The system combines enhanced sensitivity with automation to detect M-proteins at low concentrations, supporting early diagnosis of plasma cell disorders.
Be the First to Know What’s Next in the Lab
Every week, we dig into the biggest shifts, breakthroughs, and tech transforming clinical diagnostics. Straightforward, insightful, and always relevant.Critical Resources
Diagnostic Innovations
Thermo Fisher Launches Triple-Quad Mass Spectrometer Aimed at High-Throughput Workflows
The system is designed to handle more than 10,000 injections without cleaning and scan over 900 SRM transitions per second for high-throughput laboratories.
Equipment & Supply Spotlight
Azenta Launches Networked 2D-Coded Tube Readers for Laboratory Automation
The Mirage Connect and Cube Connect readers feature integrated networking capabilities and passive cryoprotection for frozen sample processing.
News, Know-How & Standards
Disease Detection & Understanding
FDA Grants Breakthrough Device Designation to Nanopath’s UTI Diagnostic Platform
The molecular diagnostic system can identify complicated UTI pathogens and antibiotic resistance markers at the point-of-care in approximately 15 minutes.
